African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2284

Full Length Research Paper

In vivo assessment of the antipyretic activity of tilmicosin

A. M. El-Mahmoudy
  • A. M. El-Mahmoudy
  • Department of Pharmacology, Benha University, 13736 Moshtohor, Egypt.
  • Google Scholar
I. M. Gheith
  • I. M. Gheith
  • Department of Medical Laboratories Technology, Faculty of Applied Medical Sciences, Taibah University, 344 Medinah, Kingdom of Saudi Arabia.
  • Google Scholar
A. A. Elmajdoub
  • A. A. Elmajdoub
  • Department of Pharmacology, Toxicology and Forensic Medicine, University of Tripoli, 13662 Tripoli, Libya.
  • Google Scholar
S. K. Awidat
  • S. K. Awidat
  • Department of Pharmacology, Toxicology and Forensic Medicine, University of Tripoli, 13662 Tripoli, Libya.
  • Google Scholar


  •  Received: 26 February 2018
  •  Accepted: 10 April 2018
  •  Published: 15 April 2018

References

Ahrens FA (1996). Pharmacology. 1st, Wiley, Iowa ed: Wiley. P 328.

 

Aronoff DM, Neilson EG (2001). Antipyretics: mechanisms of action and clinical use in fever suppression. Am. J. Med. 111:304-315.
Crossref

 
 

Bryskier A, Agouridas C, Chantot JF (2008). New medical targets for macrolides. Expert Opin. Invest. Drugs 3:405-410.
Crossref

 
 

Cao C, Matsumura K, Yamagata K, Watanabe Y (1996). Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever. Brain Res. 733:263-272.
Crossref

 
 

Croft A, Duffield T, Menzies P, Leslie K, Bagg R, Dick P (2000). The effect of tilmicosin administered to ewes prior to lambing on incidence of clinical mastitis and subsequent lamb performance. Can. Vet. J. 41:306.

 
 

El-Mahmoudy A, Gheith I (2016). The anti-nociceptive potential of tilmicosin against chemical-induced but not thermal-induced pain in mice. Int. J. Immunopathol. Pharmacol. 29:9-16.
Crossref

 
 

Faull O, Cotter J, Lucas S (2015). Cerebrovascular responses during rowing: Do circadian rhythms explain morning and afternoon performance differences? Scand. J. Med. Sci. Sports 25:467-475.
Crossref

 
 

Hunskaar S, Hole K (1987). The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30:103-114.
Crossref

 
 

Jordan F, Forrester C, Hodge A, Reeve-Johnson L (1999). The comparison of an aqueous preparation of tilmicosin with tylosin in the treatment of Mycoplasma gallisepticum infection of turkey poults. Avian Disease. pp. 521-525.
Crossref

 
 

Kirtikara K, Raghow R, Laulederkind SJ, Goorha S, Kanekura T, Ballou LR (2000). Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Mol. Cell. Biochem. 203:41-51.
Crossref

 
 

Labro M (1993). Intraphagocytic penetration of macrolide antibiotics. Macrolides: chemistry, pharmacology and clinical use. Arnette-Blackwell, Paris, France pp. 379-388.

 
 

Labro MT (1998). Anti-inflammatory activity of macrolides: a new therapeutic potential? J. Antimicrob. Chemother. 41:37-46.
Crossref

 
 

Mackowiak PA (1997). Fever: basic mechanisms and management. 2nd ed: Lippincott-Raven Publishers. P 506.

 
 

Mackowiak PA (2000). Temperature regulation and the pathogenesis of fever. Princip. Pract. Infect. Dis. 6:703-718.

 
 

Mateusen B, Maes D, Hoflack G, Verdonck M, De Kruif A (2001). A comparative study of the preventive use of tilmicosin phosphate (Pulmotil premix®) and Mycoplasma hyopneumoniae vaccination in a pig herd with chronic respiratory disease. J. Vet. Med. B. 48:733-741.
Crossref

 
 

McKay S, Morck D, Merrill J, Olson M, Chan S, Pap K (1996). Use of tilmicosin for treatment of pasteurellosis in rabbits. Am. J. Vet. Res. 57:1180-1184.

 
 

Merriam-Webster (2014). Definition of antipyretic [12-2014]. Available from: 

View

 
 

Mora N, Uribe-Querol E, Rosales C (2013). Molecular Aspects of Inflammation. In: Pérez-Martínez L, Pedraza-Alva G, Osorio EF, editors. Research signpost. Kerala, India: Research Signpost. pp.15-41.

 
 

Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T (1996). Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 156:3961-3969.

 
 

Ramadan A (1997). Pharmacokinetics of tilmicosin in serum and milk of goats. Res. Vet. Sci. 62:48-50.
Crossref

 
 

Roth J (2006). Endogenous antipyretics. Clin. Chim. Acta 371:13-24.
Crossref

 
 

Seiple IB, Zhang Z, Jakubec P, Langlois-Mercier A, Wright PM, Hog DT, Yabu K, Allu SR, Fukuzaki T, Carlsen PN (2016). A platform for the discovery of new macrolide antibiotics. Nature 533:338.
Crossref

 
 

Simon LS (1999). Role and regulation of cyclooxygenase-2 during inflammation. Am. J. Med. 106:37S-42S.
Crossref

 
 

Steel HC, Theron AJ, Cockeran R, Anderson R, Feldman C (2012). Pathogen-and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators Inflamm. 2012:584262.
Crossref

 
 

Tomazetti J, Ávila DS, Ferreira APO, Martins JS, Souza FR, Royer C, Rubin MA, Oliveira MR, Bonacorso HG, Martins MAP (2005). Baker yeast-induced fever in young rats: Characterization and validation of an animal model for antipyretics screening. J. Neurosci. Methods 147:29-35.
Crossref

 
 

Vriens J, Nilius B, Voets T (2014). Peripheral thermosensation in mammals. Nat. Rev. Neurosci. 15:573.
Crossref

 
 

Wilkinson MF, Kasting NW (1990). Central vasopressin V1-blockade prevents salicylate but not acetaminophen antipyresis. J. Appl. Physiol. 68:1793-1798.
Crossref

 
 

Xu XM, Sansores-Garcia L, Chen XM, Matijevic-Aleksic N, Du M, Wu KK (1999). Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl. Acad. Sci. 96:5292-5297.
Crossref